The East Dallas Government Center, formerly located at 3443 St. Francis Avenue, Dallas, Texas 75228, has officially relocated to a new, state-of-the-art facility.

Our New Location: 9731 Lake June Road, Dallas, Texas 75217

The former facility at 3443 St. Francis Avenue is now closed. We are excited to welcome residents, visitors, and employees to our new location, designed to provide an improved and more modern environment for serving the East Dallas community.

We look forward to serving you at our new location.
DALLAS COUNTY ADOPTED A TAX RATE THAT WILL RAISE MORE TAXES FOR MAINTENANCE AND OPERATIONS THAN LAST YEAR'S TAX RATE.

THE TAX RATE WILL EFFECTIVELY BE RAISED BY 22.02 PERCENT AND WILL RAISE TAXES FOR MAINTENANCE AND OPERATIONS ON A $100,000 HOME BY APPROXIMATELY $29.08.

Genome Sequencing Unit

The Genome Sequencing Unit leverages next-generation sequencing (NGS) technologies to support outbreak investigations, pathogen identification, and antimicrobial resistance profiling. Our state-of-the-art workflows integrate both amplicon-based and hybrid-capture methods to perform whole viral pathogen sequencing on leading platforms such as the Illumina MiSeq and Oxford Nanopore Technology or ONT MinION.

Core Capabilities & Technologies

  • Advanced NGS workflows including Illumina Microbial Amplicon Prep (IMAP) and hybrid-capture target enrichment and ONT rapid viral sequencing with targeted approaches.
  • Robust bioinformatic analysis using platforms such as Illumina BaseSpace DRAGEN, CLC Genomics Workbench, and TerraBio.
  • Quality control metrics routinely achieving high Q30 scores and optimal read depths for accurate variant calling.
  • Integrated systems ensuring seamless data transfer and interoperability with bioinformatics.

Recent Projects and Initiatives

  • Mpox Virus Sequencing: Validated an NGS workflow for detecting and classifying hMPXV clades (Clade I and II) using genome-specific primers on the Illumina MiSeq.
  • HIV Genome Sequencing & DR Mutation Analysis: Developed streamlined protocols for HIV genotyping, enabling detection of drug resistance mutations from specimens with moderate viral loads.
  • Respiratory Pathogens and SARS-CoV-2: Validated NGS protocol for sequencing SARS-CoV-2 and ongoing validation of sequencing assays for respiratory viruses including Influenza A/B and HPAI/H5N1 to enhance pathogen surveillance and outbreak response.
  • Infrastructure Enhancements: Recent system upgrades and improved instrument connectivity have augmented our sequencing capacity and data interoperability.

Impact on Public Health

Our integrated sequencing efforts provide pivotal data for tracking pathogen evolution and informing public health interventions. By rapidly identifying variants and detecting resistance mutations, the Genome Sequencing Unit contributes to targeted outbreak response and the strategic allocation of resources.

 

Connect:

Facebook logo Instagram logo X Logo Image formerly Twitter Tik Tok secondary logo